OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BGHYDR.BB55

Green Innovation AD

Advanced Medical Equipment & TechnologyVerified

Green Innovation AD maintains a conservative capital structure, with a debt-to-equity ratio of 0.09, indicating a strong equity position relative to its liabilities. The company's liquidity is reflected in a current ratio of 6.94, suggesting it has ample short-term assets to cover its short-term obligations. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Green Innovation AD's financials do not provide direct metrics such as ROIC or EBITDA margins. However, the company's low debt load and high equity base suggest a stable financial foundation, which is favorable for long-term returns. The industry_config for Advanced Medical Equipment & Technology emphasizes metrics like R&D intensity and operating margins, which are not disclosed in the current financial snapshot. The company's revenue concentration is not disclosed in the available data, but the absence of segment or geographic breakdowns implies a potentially concentrated exposure. This could pose a risk if the company relies heavily on a single product line or geographic market. Green Innovation AD's growth trajectory is not explicitly outlined in the financial data, but the company's current financial position supports potential for expansion. The outlook for the current fiscal year is not provided, but the absence of negative indicators in the risk assessment suggests a stable or improving outlook. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's dilution potential is minimal, as the number of basic and diluted shares outstanding is identical, indicating no imminent threat from share dilution. No specific dilution sources are identified in the available data. Recent events, such as filings or transcripts, are not detailed in the provided data. However, the company's financial stability and low debt suggest a conservative approach to capital management, which may be reflected in its recent strategic decisions.

30-day price · BGHYDR.BB+0.30 (+3.3%)
Low$9.00High$9.95Close$9.45As of17 May, 00:00 UTC
Profile
CompanyGreen Innovation AD
TickerBGHYDR.BB
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Green Innovation AD designs and manufactures advanced medical equipment and technology, primarily serving the healthcare services and equipment sector.

Classification. Green Innovation AD is classified under the industry "Advanced Medical Equipment & Technology" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Green Innovation AD maintains a conservative capital structure, with a debt-to-equity ratio of 0.09, indicating a strong equity position relative to its liabilities. The company's liquidity is reflected in a current ratio of 6.94, suggesting it has ample short-term assets to cover its short-term obligations. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Green Innovation AD's financials do not provide direct metrics such as ROIC or EBITDA margins. However, the company's low debt load and high equity base suggest a stable financial foundation, which is favorable for long-term returns. The industry_config for Advanced Medical Equipment & Technology emphasizes metrics like R&D intensity and operating margins, which are not disclosed in the current financial snapshot. The company's revenue concentration is not disclosed in the available data, but the absence of segment or geographic breakdowns implies a potentially concentrated exposure. This could pose a risk if the company relies heavily on a single product line or geographic market. Green Innovation AD's growth trajectory is not explicitly outlined in the financial data, but the company's current financial position supports potential for expansion. The outlook for the current fiscal year is not provided, but the absence of negative indicators in the risk assessment suggests a stable or improving outlook. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's dilution potential is minimal, as the number of basic and diluted shares outstanding is identical, indicating no imminent threat from share dilution. No specific dilution sources are identified in the available data. Recent events, such as filings or transcripts, are not detailed in the provided data. However, the company's financial stability and low debt suggest a conservative approach to capital management, which may be reflected in its recent strategic decisions.
Key takeaways
  • Green Innovation AD has a strong equity position with a debt-to-equity ratio of 0.09.
  • The company's current ratio of 6.94 indicates robust short-term liquidity.
  • The risk assessment notes a negative net cash position after subtracting total debt.
  • The company's growth trajectory and segment exposure are not explicitly detailed in the available data.
  • Green Innovation AD has a low dilution risk, with no difference between basic and diluted shares outstanding.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$6.9M
Total liabilities$1.1M
Total equity$5.7M
Cash & equivalents
Long-term debt$529.0k
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$5.7M
Net cash-$529.0k
Current ratio6.9
Debt/Equity0.1
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Advanced Medical Equipment & Technology · cohort 109 companies
MetricBGHYDR.BBActivity
Op margin-19.9% medp25 -150.5% · p75 8.7%
Net margin-18.4% medp25 -146.8% · p75 8.0%
Gross margin49.9% medp25 36.2% · p75 66.3%
R&D / revenue6.2% medp25 4.7% · p75 12.0%
CapEx / revenue-3.5% medp25 -7.8% · p75 -1.4%
Debt / equity9.0%14.5% medp25 0.9% · p75 54.2%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 17:22 UTC#5b011f52
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 11:56 UTCJob: 37cd4852